Accession Number: | 0001209191-20-045866 |
Date: | 2020-08-06 |
Issuer: | BIOLASE, INC (BIOL) |
Original Submission Date: |
ROPER JESS
4 CROMWELL
IRVINE, CA 92618
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNIT | 0.0 | 2020-08-06 | deemed execution date | A | 20,000 (a) | common stock 20,000 | $0.00 | 260,397 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents the right to receive, at settlement, one share of common stock. |
f2 | the restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award, subject to the reporting person's continued service. |